Literature DB >> 11060542

Treatment of severe complicated Kawasaki disease with oral prednisolone and aspirin.

R C Dale1, M A Saleem, S Daw, M J Dillon.   

Abstract

We report on 7 patients with severe, complicated Kawasaki disease treated with oral prednisolone, after apparently unsuccessful intravenous immunoglobulin treatment. An additional eighth patient was a Jehovah's Witness, who was given steroid and aspirin as first-line treatment. These findings support a beneficial role for steroids in intravenous immunoglobulin-resistant Kawasaki disease.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11060542     DOI： 10.1067/mpd.2000.108444

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


  15 in total

1.  Kawasaki disease: an evidence based approach to diagnosis, treatment, and proposals for future research.

Authors:  P A Brogan; A Bose; D Burgner; D Shingadia; R Tulloh; C Michie; N Klein; R Booy; M Levin; M J Dillon
Journal:  Arch Dis Child       Date:  2002-04       Impact factor: 3.791

Review 2.  Use of corticosteroids during acute phase of Kawasaki disease.

Authors:  Jeong Jin Yu
Journal:  World J Clin Pediatr       Date:  2015-11-08

3.  Anti-inflammatory effect of intravenous immunoglobulin in comparison with dexamethasone in vitro: implication for treatment of Kawasaki disease.

Authors:  Haruyuki Makata; Takashi Ichiyama; Ryutaro Uchi; Tsuyoshi Takekawa; Tomoyo Matsubara; Susumu Furukawa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-08-01       Impact factor: 3.000

4.  Pulse methylprednisolone with gammaglobulin as an initial treatment for acute Kawasaki disease.

Authors:  Keiko Okada; Junichi Hara; Ichiro Maki; Kazunori Miki; Kouji Matsuzaki; Taro Matsuoka; Takehisa Yamamoto; Toshinori Nishigaki; Syunji Kurotobi; Tetsuya Sano
Journal:  Eur J Pediatr       Date:  2008-04-30       Impact factor: 3.183

5.  The use of corticosteroid therapy in refractory Kawasaki patients.

Authors:  Sulaiman M Al-Mayouf
Journal:  Clin Rheumatol       Date:  2003-12-16       Impact factor: 2.980

Review 6.  Vasculitis treatment - new therapeutic approaches.

Authors:  Michael J Dillon
Journal:  Eur J Pediatr       Date:  2006-03-09       Impact factor: 3.183

Review 7.  Advances in Kawasaki disease.

Authors:  Stanford T Shulman; Anne H Rowley
Journal:  Eur J Pediatr       Date:  2004-06       Impact factor: 3.860

8.  Kawasaki disease.

Authors:  Jane W Newburger; David R Fulton
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-04

9.  Kawasaki Disease: Current Therapeutic Perspectives.

Authors:  Erik C. Michelfelder; David Shim
Journal:  Curr Treat Options Cardiovasc Med       Date:  2002-08

Review 10.  Medium-size-vessel vasculitis.

Authors:  Michael J Dillon; Despina Eleftheriou; Paul A Brogan
Journal:  Pediatr Nephrol       Date:  2009-11-28       Impact factor: 3.714
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.